MacroGenics
MGNX
#8653
Rank
โ‚ฌ0.20 B
Marketcap
3,24ย โ‚ฌ
Share price
-7.73%
Change (1 day)
128.26%
Change (1 year)

MacroGenics (MGNX) - Net assets

Net assets on the balance sheet as of March 2026 : โ‚ฌ18.57 Million

According to MacroGenics's latest financial reports the company has โ‚ฌ18.57 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

MacroGenics - Net assets on balance sheet (from 2012 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$โ‚ฌ47.32 M-57.57%
2024-12-31$โ‚ฌ0.11 B-19.21%
2023-12-31$โ‚ฌ0.13 B4.28%
2022-12-31$โ‚ฌ0.13 B-37.43%
2021-12-31$โ‚ฌ0.21 B-12.05%
2020-12-31$โ‚ฌ0.24 B16.85%
2019-12-31$โ‚ฌ0.20 B-3.03%
2018-12-31$โ‚ฌ0.21 B-14.87%
2017-12-31$โ‚ฌ0.24 B-2.39%
2016-12-31$โ‚ฌ0.25 B-10.84%
2015-12-31$โ‚ฌ0.28 B187.36%
2014-12-31$โ‚ฌ99.72 M74.52%
2013-12-31$โ‚ฌ57.14 M-1017.61%
2012-12-31$-โ‚ฌ6.23 Million-53.75%
2011-12-31$-โ‚ฌ13.47 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
โ‚ฌ79.22 B 426,374.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ27.33 B 147,074.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ8.05 B 43,253.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ20.53 B 110,434.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ40.24 B 216,576.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ17.61 B 94,729.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.45 B 2,332.46%๐Ÿ‡บ๐Ÿ‡ธ USA